エピソード
-
Matteo Trucco, MD, Director of the Children’s Cancer Innovative Therapy Program, joins the Cancer Advances Podcast to discuss the Cleveland Clinic Children's recent recognition as the first center in the nation to receive pediatric cancer subcommittee accreditation from the Commission on Cancer. Learn how this milestone is not only advancing pediatric cancer care at Cleveland Clinic but also shaping national benchmarks for multidisciplinary pediatric oncology programs.
-
Chair of the Department of Gastroenterology, Hepatology and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss her team’s innovative work using electronic health records (EHR) to develop a predictive model for noncardiac gastric cancer. Listen as Dr. Kim explains how the model uses common clinical variables to flag high-risk patients who may benefit from endoscopic screening.
-
エピソードを見逃しましたか？
-
Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.
-
The Cancer Advances Podcast welcomes back Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, to explore the evolving landscape of survivorship care. Listen as Dr. Singh provides insights on how personalized, patient-centered approaches are being integrated with shared care models to address late effects, psychological challenges, and the needs of a growing population of cancer survivors.
-
Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, joins the Cancer Advances Podcast to discuss a major new study exploring the link between GLP-1 receptor agonists and the risk of hematologic malignancies in patients with diabetes. Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.
-
The Cancer Advances Podcast is joined by the Chair of the Division of Pediatric Hematology Oncology and Director of the Bone Marrow Transplant Program, Rabi Hanna, MD, along with Ilia Butoriarov, MD, a physician at the Division of Pediatric Hematology Oncology leading the Leukemia Lymphoma Program to discuss evolving approaches to treating pediatric Hodgkin lymphoma. Listen as they talk about how novel therapies, including checkpoint inhibitors and PET-guided treatment strategies, are reshaping patient care and help avoid the need for bone marrow transplant.
-
Alok Khorana, MD, Director of the Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to break down the latest research on early-onset biliary tract cancer, diving into the genetic and molecular differences that set it apart. Listen as Dr. Khorana addresses the challenges in diagnosing and treating this cancer and the exciting potential for personalized therapies tailored to these molecular discoveries.
-
Michael Fritz, MD, Director of the Section of Facial Plastic and Reconstructive Surgery at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the approaches to the classification and management of mandibular osteoradionecrosis (ORN). Listen as Dr. Fritz shares insights into the classification and treatment of ORN, including the role of PENTO therapy and the groundbreaking anterolateral thigh rescue flap technique, highlighting the importance of early intervention and how multidisciplinary collaboration can improve patient outcomes.
-
The Cancer Advances podcast is joined by hematologists Sandra Mazzoni, DO and Shahzad Raza, MD to discuss the latest advancements in multiple myeloma treatment. Listen as they explore the evolving role of CAR-T cell therapy, bispecific antibodies, and autologous stem cell transplants and how they are changing the multiple myeloma treatment landscape.
-
Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer at Cleveland Clinic, joins the Cancer Advances podcast to discuss the challenges of trying to detect ovarian cancer early and the need for better predictive tools. Listen as Dr. Elias talks about the MiDe Study, which aims to identify high-risk women through microRNA-based blood tests, potentially transforming ovarian cancer screening and prevention.
-
Gloria Gonzalez, MD, Pediatric Surgeon and Director of Pediatric Surgical Oncology, joins the Cancer Advances podcast to provide her insights on advanced surgical techniques for neuroblastoma. Listen as Dr. Gonzalez explains the complexities of neuroblastoma, the use of 3D printing in preoperative planning and 3D image-guided surgery, and the emerging role of fluorescent-guided surgery.
-
The Cancer Advances podcast is joined by the Chair of the Palliative and Supportive Care Department, Laura Shoemaker, DO, and Integrative Medicine Specialist, Naoki Umeda, MD, to talk about Cleveland Clinic’s Integrative Oncology Program. Listen as they share how combining evidence-based complementary therapies, such as acupuncture and lifestyle medicine, with conventional cancer treatment can help alleviate symptoms, enhance patients' quality of life, and improve outcomes.
-
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Institute, joins the Cancer Advances podcast to discuss the latest advancements in immunotherapy for aggressive lymphomas. Listen as Dr. Caimi talks about the potential of bispecific antibody combinations, including early-phase findings on glofitamab plus ICE chemotherapy for relapsed and refractory diffuse large B-cell lymphoma.
-
Vice Chair of the Center for Immunotherapy & Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenhorst explains how advancements in cell therapy are overcoming challenges like T cell exhaustion, improving response rates, and how novel approaches could improve treatment outcomes.
-
Moshe Ornstein, MD, MA, a Genitourinary Medical Oncologist joins the Cancer Advances podcast to talk about intermittent therapy for metastatic renal cell carcinoma (mRCC). Listen as Dr. Ornstein explores the evolution of treatment options, from cytokine and targeted therapies to immunotherapy, and as he delves into the promising concept of treatment breaks to improve patient outcomes.
-
Medical Oncologist in the Lymphoid Malignancies Division, Taylor Brooks, MD, joins the Cancer Advances podcast to discuss real-world data on bispecific antibodies for relapsed or refractory large B-cell lymphomas that was presented at the 2024 American Society of Hematology (ASH) Annual Meeting. Listen as Dr. Brooks shares insights into efficacy, safety, and challenges patients face outside clinical trial parameters, and how these therapies are reshaping treatment approaches.
-
Lukas Nystrom, MD, Orthopaedic Oncology Surgeon and a Co-Director of the Sarcoma Program at Cleveland Clinic joins the Cancer Advances Podcast to talk about the advancements in custom 3D-printed implants for pelvic sarcoma reconstruction. Listen as Dr. Nystrom explains how these personalized implants are transforming sarcoma care by enhancing precision during tumor resections, offering tailored solutions for complex pelvic reconstructions and improving patient outcomes.
-
Ruth Keri, PhD, Associate Director for Basic Research at Case Comprehensive Cancer Center and Professor of Cancer Biology at Cleveland Clinic, returns to the Cancer Advances Podcast to share the latest advancements in targeting YES1 protein to treat triple-negative breast cancer (TNBC). Listen as Dr. Keri discusses how YES1 impacts chemotherapy resistance, tumor growth, and EGFR inhibition, uncovering promising therapeutic opportunities and the potential clinical trials to improve outcomes for patients facing this aggressive cancer.
-
The Cancer Advances podcast is joined by Director of Pediatric Radiation Oncology, Erin Murphy, MD, and resident physician, Jenna Kocsis, MD, to share their latest findings on the use of stereotactic body radiation therapy (SBRT) to treat recurrent osteosarcoma. Listen as they discuss the challenges of managing this radio-resistant tumor, including its use in complex cases involving the spine and epidural space, and explore emerging techniques that have the potential to transform cancer care for young patients while reducing long-term side effects.
-
Theresa Callard-Moore, PhD, LSW, a psychotherapist and certified sex therapist at Cleveland Clinic, joins the Cancer Advances podcast to shed light on the often-overlooked topic of sexual health in cancer patients. In this episode, Dr. Callard-Moore emphasizes the importance of initiating open conversations about sexual health early in the care journey. She also shares valuable insights, practical strategies, and resources to help patients feel heard and supported to address their concerns.
- もっと表示する
